LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

Search

Tilray Inc

Fechado

SetorSaúde

0.42 -8.7

Visão Geral

Variação de preço das ações

24h

Atual

Mín

0.42

Máximo

0.44

Indicadores-chave

By Trading Economics

Rendimento

-708M

-794M

Vendas

-118M

186M

EPS

-0.869

Margem de lucro

-427.136

Funcionários

2,650

EBITDA

-585M

-626M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+121.43% upside

Dividendos

By Dow Jones

Próximos Ganhos

28 de jul. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-579M

449M

Abertura anterior

9.12

Fecho anterior

0.42

Sentimento de Notícias

By Acuity

75%

25%

350 / 381 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bullish Evidence

Tilray Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

8 de abr. de 2025, 12:06 UTC

Conversa de Mercado

Tilray Reckons Sales Won't Be Dented by Tariffs -- Market Talk

Comparação entre Pares

Variação de preço

Tilray Inc Previsão

Preço-alvo

By TipRanks

121.43% parte superior

Previsão para 12 meses

Média 0.93 USD  121.43%

Máximo 1.5 USD

Mínimo 0.6 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Tilray Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

6 ratings

2

Comprar

4

Manter

0

Vender

Pontuação Técnica

By Trading Central

0.421 / 0.4898Suporte e Resistência

Curto Prazo

Weak Bullish Evidence

Médio Prazo

Bullish Evidence

Longo Prazo

No Evidence

Sentimento

By Acuity

350 / 381 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Tilray Inc

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Beverage Alcohol, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Charlotte's Web, Montauk Brewing, Shock Top, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point Brewing, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Bake Sale, The Batch, HEXO, Alpine Beer Company, Green Flash, Hiball Energy, Redhook Brewery, Square Mile Cider, Widmer Brothers Brewing, Runner's High Brewing Company, Happy Flower, and Fresh Hemp Foods brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.